MCD vs PPCB · P/E 23, rev $25.92B vs P/E 0.0, $3.9M cap
McDonald’s Corporation (MCD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
PPCB does not have a complete income-statement cache yet.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the MCD and PPCB stock pages for the full models.
Not investment advice.